Moores Cancer Center at UC San Diego Health is San Diego’s only National Cancer Institute-designated comprehensive cancer center, one of 58 such centers in the nation, and is ranked No. 44 in the country for cancer care by U.S. News & World Report for 2026-27. Its oncologists set treatment standards nationwide for more than 200 types of cancer, and the center’s researchers rank ninth in the world for most highly cited cancer research. More than 390 clinical trials are currently enrolling patients at Moores, giving them access to new treatments before they become available to the public. The center holds accreditation from the Commission on Cancer of the American College of Surgeons, which sets quality-of-care measures for breast and colorectal cancer, along with accreditation from the Foundation for the Accreditation of Cellular Therapy and designation as an American College of Radiology comprehensive breast imaging center. The cancer center is also a member of the National Comprehensive Cancer Network and holds the Commission on Cancer’s National Accreditation Program for Rectal Cancer designation. In June 2026, the cancer center received a five-year, $25 million cancer center support grant from the National Cancer Institute, which covers about 25% of the center’s operating costs and will fund clinical discoveries, expanded regional access to cancer care, and training for the next generation of cancer researchers.
